Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) is a relatively uncommon disease. However, it accounts for about one quarter of adult cases of ALL. Due to the paucity of patients, randomized controlled trials of therapy are unusual. This, together with the fact that
No takes yet. Share an insight, caveat, or question.
Adele Kay Fielding (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: